InflaRx N.V.
izicopan
hidradenitis suppurativa (HS)
Resolved
110days ago
Catalyst readout · Mar 19, 2026
What's at stake
A key catalyst for izicopan (hidradenitis suppurativa (HS)) is expected Mar 19, 2026.
Primary source
· SEC 6-K
verified 13h ago
“Substantial progress made toward Phase 2b readiness for izicopan in hidradenitis suppurativa (HS)”